These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8841703)

  • 1. Use of nimodipine in the medical treatment of Menière's disease: clinical experience.
    Lassen LF; Hirsch BE; Kamerer DB
    Am J Otol; 1996 Jul; 17(4):577-80. PubMed ID: 8841703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical indicators useful in predicting response to the medical management of Meniere's disease.
    Devaiah AK; Ator GA
    Laryngoscope; 2000 Nov; 110(11):1861-5. PubMed ID: 11081600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
    Kilpatrick JK; Sismanis A; Spencer RF; Wise CM
    Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
    Perez N; Martin E; Zubieta JL; Romero MD; Garcia-Tapia R
    Laryngoscope; 2002 Jun; 112(6):1104-9. PubMed ID: 12160282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic steroid injections for intractable Ménière's disease.
    Barrs DM; Keyser JS; Stallworth C; McElveen JT
    Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimodipine for the treatment of otolaryngic indications.
    Sin JH; Shafeeq H; Levy ZD
    Am J Health Syst Pharm; 2018 Sep; 75(18):1369-1377. PubMed ID: 30190294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
    Li CS; Lai JT
    Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple semicircular canal occlusion for the treatment of Ménière's disease.
    Yin S; Chen Z; Yu D; Wu Y; Shi H; Zhou H; Wang J
    Acta Otolaryngol; 2008 Jul; 128(7):739-43. PubMed ID: 18568514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M; Marsan J; Schramm D; Robichaud J
    J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.
    Monzani D; Barillari MR; Alicandri Ciufelli M; Aggazzotti Cavazza E; Neri V; Presutti L; Genovese E
    Acta Otorhinolaryngol Ital; 2012 Dec; 32(6):393-403. PubMed ID: 23349559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of Meniere's disease.
    Slattery WH; Fayad JN
    Otolaryngol Clin North Am; 1997 Dec; 30(6):1027-37. PubMed ID: 9386239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE; Kamerer DB
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.